Macrophage reprogramming combined with enhanced photodynamic therapy increases the patency of malignant esophageal obstruction after stenting

Esophageal cancer (EC) is a disease characterized by progressive malignant obstruction. Stent implantation restores lumen patency, but tumor progression is likely to cause re-occlusion shortly. An esophageal stent loaded with Ce6-SiO @MnO nanoparticles was designed, for which a dense δ-MnO coating w...

Full description

Saved in:
Bibliographic Details
Published inNanoscale Vol. 16; no. 34; pp. 16035 - 16047
Main Authors Xu, Haoyang, Zhang, Yiran, Guo, Sheng, Fang, Hui, Wei, Liming, He, Guangchen, Cheng, Yingsheng, Zhu, Yueqi
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 29.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Esophageal cancer (EC) is a disease characterized by progressive malignant obstruction. Stent implantation restores lumen patency, but tumor progression is likely to cause re-occlusion shortly. An esophageal stent loaded with Ce6-SiO @MnO nanoparticles was designed, for which a dense δ-MnO coating was synthesized using a novel one-step REDOX reaction. This stent reverses the hypoxic tumor microenvironment (TME) explosive oxygen generation, thereby increasing the efficacy of photodynamic therapy (PDT). Furthermore, Mn reprograms the polarity of tumor associated macrophages (TAMs) in the immunosuppressed TME to effectively activate innate anti-tumor immunity in combination with PDT. Mn downregulates the high mobility group box 1 protein (HMGB1), upregulates the signal transducer and activator of transcription 1 (STAT1) mRNA, and ultimately expresses the tumor inhibition effect of TAMs. Additionally, Ce6-SiO @MnO effectively suppresses the apoptosis of TAMs to enhance their anti-tumor effect. The proposed strategy highlights the multifaceted role of Ce6-SiO @MnO in the treatment of advanced esophageal cancer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2040-3364
2040-3372
2040-3372
DOI:10.1039/d4nr01140f